What is ESLAW's relative strength rating?

Relative strength percentiles for ESLAW are not available for the current snapshot date. TickerStance publishes RS ratings daily after each session close; check back after the next pipeline run.

What sector is ESLAW in?

ESLAW is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.

Is ESLAW in a leading sector?

Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). ESLAW benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.

How volatile is ESLAW?

Volatility metrics for ESLAW — average daily range (ADR%), average true range (ATR%), and beta — are not available for the current snapshot. These indicators update daily with each pipeline run.

Does ESLAW have a seasonal pattern?

TickerStance computes ESLAW's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what ESLAW has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

When did ESLAW last report earnings?

No SEC EDGAR filings are linked to ESLAW in the current TickerStance fundamentals database. This can occur for tickers without a matched CIK (some ADRs, ETFs, and recently listed securities) or when the fundamentals pipeline has not yet processed this ticker.

Estrella Immunopharma, Inc. Warrant (ESLAW)

TODAY'S READ · AS OF 2026-08-24

As of 2026-08-24, Estrella Immunopharma, Inc. Warrant (ESLAW) has a 3-month relative strength percentile of — within the TickerStance CS+ADRC universe (~5,000 tickers). The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.

RS methodology →

Market-wide RS; lit = leaderboard

Lenses lit

3 month—pctile

6 month—pctile

1 year—pctile

Classic—IBD pctile

LDR—leadership

0 of 5 lenses lit · avg RS pctile —

!ADR%—!A/D—!RVOL—!$ Vol—

Market backdrop

47.8Neutral

Trend30% weight44.9 Breadth30% weight50.6 Leadership20% weight42.4 Macro20% weight59.0 Full stance breakdown →

§ Seasonality

10y · since 2023

Best monthOct on averageavg +38.82% · 67% win · n 3

Worst monthNov on averageavg -24.70% · 0% win · n 3

ESLAW monthly seasonality strip
	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
1	ESLAW Jan avg: -7.58% median: 0.66% win: 67% σ: 32.50% n: 3 2023-10-03 → 2026-07-31	ESLAW Feb avg: 24.84% median: 26.67% win: 100% σ: 8.68% n: 3 2023-10-03 → 2026-07-31	ESLAW Mar avg: 31.06% median: 28.50% win: 67% σ: 33.86% n: 3 2023-10-03 → 2026-07-31	ESLAW Apr avg: 29.98% median: 14.79% win: 100% σ: 36.07% n: 3 2023-10-03 → 2026-07-31	ESLAW May avg: -18.72% median: -1.74% win: 33% σ: 35.62% n: 3 2023-10-03 → 2026-07-31	ESLAW Jun avg: 10.35% median: 1.62% win: 67% σ: 19.84% n: 3 2023-10-03 → 2026-07-31	ESLAW Jul avg: 4.32% median: -5.05% win: 33% σ: 36.83% n: 3 2023-10-03 → 2026-07-31	ESLAW Aug avg: -10.09% median: -10.09% win: 0% σ: 14.27% n: 2 2023-10-03 → 2026-07-31 (current)	ESLAW Sep avg: 4.09% median: 4.09% win: 50% σ: 56.27% n: 2 2023-10-03 → 2026-07-31	ESLAW Oct avg: 38.82% median: 42.92% win: 67% σ: 95.15% n: 3 2023-10-03 → 2026-07-31	ESLAW Nov avg: -24.70% median: -17.57% win: 0% σ: 27.98% n: 3 2023-10-03 → 2026-07-31	ESLAW Dec avg: -21.09% median: -14.77% win: 33% σ: 25.83% n: 3 2023-10-03 → 2026-07-31

Evidence · 1 of 3

Receipts behind the read

0 of 5 pass

Leadership

Is it leading?

Relative strength across horizons plus the leadership score.

1m

—

3m

—

6m

—

1y

—

LDR

—

StageWeinstein stage analysis

—

Smart money

Who's accumulating?

Accumulation rating, relative volume, U/D ratio, breakout-day proof.

Fundamentals · ESLAW

Does the business back the chart?

No SEC filings on file for this ticker. Fundamentals section requires EDGAR coverage.

Evidence · 2 of 3

Sector context

Healthcare · 82th pctile in sector

Top peers · Healthcare

Who else is leading?

ELOX
99RS 3m
FBRX
99RS 3m
MRNA
99RS 3m

Sector vs market

Healthcare · 3 of 11

Energy100

Technology91

Healthcare82

Financials73

Materials64

Industrials

Public attention · ESLAW

Is the crowd watching?

No attention data for this ticker yet — it joins the daily scan once a baseline builds.

Reference

Company snapshot

SectorHealthcare

IndustryPharmaceutical Products

SIC2836

Floatn/a

Shares outn/a

Market capn/a

FAQ

Frequently asked questions

What is ESLAW's relative strength rating?: Relative strength percentiles for ESLAW are not available for the current snapshot date. TickerStance publishes RS ratings daily after each session close; check back after the next pipeline run.
What sector is ESLAW in?: ESLAW is classified under the Healthcare sector within the Pharmaceutical Products industry per the TickerStance sector-classification pipeline, which maps U.S. equities to GICS-aligned sectors using exchange SIC codes and Massive Finance reference data. Healthcare is currently ranked 3 of 11 sectors by relative strength.
Is ESLAW in a leading sector?: Yes — Healthcare ranks at the 82th percentile by sector relative strength, placing it in the leading band (≥ 70th percentile). ESLAW benefits from positive sector-level momentum, which historically correlates with above-average stock-level RS performance in the O'Neil / Minervini framework.
How volatile is ESLAW?: Volatility metrics for ESLAW — average daily range (ADR%), average true range (ATR%), and beta — are not available for the current snapshot. These indicators update daily with each pipeline run.
Does ESLAW have a seasonal pattern?: TickerStance computes ESLAW's month-by-month seasonality from its full daily price history: the average and median return for each calendar month, how often that month closed higher, and the best and worst months on record. These are historical frequencies, not forecasts — a strong seasonal month describes what ESLAW has tended to do in prior years, not a prediction of what comes next. The full month-by-month heatmap and win-rate table sit higher on this page.

Estrella Immunopharma, Inc. Warrant (ESLAW) — Stance & relative strength

Lenses lit

Market backdrop

§ Seasonality

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?

§ Seasonality

Estrella Immunopharma, Inc. Warrant (ESLAW) — Stance & relative strength

ESLAW is not confirmed as a leader. 3m RS is unavailable, Market Stance is 47.8

Lenses lit

Market backdrop

Receipts behind the read

Is it leading?

Who's accumulating?

Does the business back the chart?

Sector context

Who else is leading?

Healthcare · 3 of 11

Is the crowd watching?

Company snapshot

Frequently asked questions

How much does it move?